Objective: Rapid on-site evaluation (ROSE) has been shown to be beneficial in determining the adequacy and a preliminary diagnosis in multiple organ systems.
| INTRODUCTION
Fine needle aspiration (FNA) has been widely accepted as a preoperative and screening diagnostic modality of salivary gland lesions in light of its easy accessibility, safety and cost-effectiveness. FNA cytology of the salivary gland has been reported to have acceptable sensitivity, high specificity and high diagnostic accuracy. However, these values vary across studies and sensitivity can be as low as 58%. [1] [2] [3] [4] [5] [6] Cytology provides additional information which may help clinicians to risk-stratify patients and decide whether clinical followup or surgery is required. In addition, a meta-analysis reported a reduction in the number of surgeries and the overall cost when FNA was included into the initial assessment. 7 Inadequacy is an important limitation of salivary gland FNA and ranges from 3% to 28.2%. [8] [9] [10] Rapid on-site evaluation (ROSE) is a service that cytopathologists provide primarily to check the adequacy of FNA specimens and decide whether the additional passes are needed for ancillary studies and to increase the diagnostic yield.
In addition, ROSE provides a preliminary diagnosis so that rapid clinical decisions can be made.
At our institution, loss to follow-up and a delay in surgery owing to insufficient resources have been an important issue in managing patients with salivary gland malignancy. Our cytopathologists established an FNA clinic and had performed ROSE to help head and neck surgeons triage patients and identify those who are in greatest need of surgery.
To our knowledge, there are few data in the literature regarding ROSE in salivary gland FNA. A retrospective analysis was, therefore, conducted exclusively in salivary gland lesions at our institution.
The aim was to determine the diagnostic accuracy of ROSE and agreement between ROSE and the final cytological diagnosis of FNA from salivary gland lesions and to identify causes of the discrepancy. All lesions were palpable and aspirated without ultrasound guidance by pathology residents and attending cytopathologists at our FNA clinic where the procedures were performed using 22-gauge needles without negative suction (French technique). 11 Usually, one pass was performed for each lesion. An additional one or two passes were made if the first ROSE showed to be inadequate. All specimens were processed by the conventional smear method, typically providing four smears. Two air-dried smears were stained using DiffQuickâ stain (Merck, Darmstadt, Germany) and subsequently evaluated on-site for provisional interpretation. While one or two sprayfixed smears (spray fixative containing 4% w/v carbowax, 1% v/v acetone in absolute isopropanol) were later stained using Papanicolaou stain. All smears prepared by both stains were evaluated to render the final cytological diagnosis.
| MATERIALS AND METHODS
All aspirate smears were reviewed by one author (S.W.). Cases in which a discrepancy was found between ROSE and the final cytological diagnosis were again reviewed by two authors (S.W and S.R.)
and assessed whether the discrepancy was major or minor. A major discrepancy was defined as a discrepancy with implications for clinical management whereas, in a minor discrepancy, there would be no different clinical implication.
Given that there had been no standard system for reporting salivary gland cytopathology at the time of the study, both on-site and final interpretations were categorised into six groups. The detailed description for each category is provided as follows:
• Inadequate -This category included the aspirate that lacked cells or matrix sufficient to make a diagnosis or contained only bloody material.
• • Atypical -This entity was referred to lesions when few atypical cells containing enlarged, slightly hyperchromatic nuclei were present but not sufficient to make a diagnosis of malignancy and reactive/benign vs malignant processes could not be distinguished.
• Suspicious for malignancy -Abnormal cytological features were present but not sufficient to make a definitive diagnosis of malignancy.
• Positive for malignancy -Abnormal cytological features clearly indicated a malignant neoplasm. This also included metastatic lesions.
• Indeterminate -This group is heterogeneous and was applied when specimens had sufficient cellularity but could not be designated into any of the groups mentioned above. This included specimens with cellular atypia that was significantly obscured by other cellular or stromal components, cystic lesions containing a mucoid background without other significant cytological elements of mucoepidermoid carcinoma, and aspirates containing monotonous lymphoid population with a significant crush artefact. Table 2 ). There was discordance in 25 cases (6.8%) between ROSE and the final cytological interpretation. Of these, 10 (2.7%) lesions were major discrepancies (Table 3) , 8 (2.2%) were minor discrepancies (Table 4) , and 7
| Statistical analysis
(1.9%) were indeterminate lesions on ROSE which had diagnosis change on final interpretation. Most of the major discrepancies occurred in pleomorphic adenoma (five specimens) whereas most of the minor discrepancies were adenoid cystic adenoma (three specimens). Interestingly, of the 36 lesions initially reported as malignant lesions by ROSE, only one (2.7%) was downgraded to suspicious for malignancy by final cytological diagnosis. Of the 304 lesions initially interpreted as benign lesions, six (2%) were upgraded to suspicious for malignancy or malignant results (case 1-6, Table 3 ) and three Epithelial-myoepithelial carcinoma 1 (0.5) specificity, PPV and NPV of ROSE using "atypical" as a cut-off point were 69%, 93%, 83% and 86%, respectively. Table 7 shows "indeterminate" and "inadequate" ROSE cases which had a corresponding final histological diagnosis. Of four (4/ 171, 2.3%) specimens interpreted as "indeterminate" on ROSE, three were signed out as benign on the final cytological diagnosis as well as a final histological diagnosis whereas the other was interpreted as suspicious and diagnosed as low-grade mucoepidermoid carcinoma in histopathology. Eight (8/171, 4.6%) specimens were interpreted as "inadequate" on ROSE. Only one FNA had a diagnosis changed to benign on the final cytological interpretation whereas the others remained as inadequate.
The ROC curves in 159 aspirates, which excluded the inadequate and indeterminate cases, and had histological follow-up are shown in 
| DISCUSSION
FNA is a minimally invasive and acceptably accurate method to diagnose salivary gland lesions. In previous studies, ROSE has been shown to improve the adequacy rate in head and neck specimens including salivary glands. 12 Pleomorphic adenoma was the most common neoplasm in our series (30.9%), followed by Warthin's tumor (6.4%), compatible with well-documented data in the literature. Mucoepidermoid carcinoma was the most common malignant neoplasm. Of 386 FNAs with ROSE performed, 6.8% of cases had discordance between the preliminary and final cytological interpretation, similar to previously published data which had a concordance rate ranging from 82% to 100%. [14] [15] [16] The most common category change from indeterminate ROSE to benign final cytological diagnosis is not surprising as additional material and/or ancillary studies were available at sign out.
One indeterminate ROSE from a patient who had a previous history Ten major discrepancies (Table 3) included pleomorphic adenoma (5 specimens), Warthin tumor (one specimen), diffuse large Bcell lymphoma (one specimen), acute lymphoblastic leukaemia/lymphoma (one specimen), chronic sialadenitis (one specimen) and lowgrade mucoepidermoid carcinoma (one specimen). Three cases of pleomorphic adenoma were interpreted as suspicious/positive for carcinoma ex-pleomorphic adenoma by final cytological interpretation. These aspirates yielded very cellular smears containing little matrix and extensive cytological atypia without necrosis or mitoses.
We believe that these overcalls may be because of the unfamiliarity with the cytological features of carcinoma ex-pleomorphic adenoma and instead, these aspirated should have been diagnosed as "pleomorphic adenoma with atypia". Eight minor discrepancies (Table 4) included adenoid cystic carcinoma (three specimens), basal cell adenocarcinoma (one specimen), Warthin's tumour (one specimen), metastatic undifferentiated nasopharyngeal carcinoma (one specimen) and two cases that were lost to follow-up. The main reason behind these discrepancies is the difficulty in diagnosing a specific entity of basaloid tumours and tumours that can exhibit basaloid features, such as pleomorphic adenoma. Thus, the reports were signed out as suspicious for malignancy with a comment on the differential diagnosis, making these cases fall into the suspicious category.
A malignant ROSE diagnosis had a high concordance rate with The present study is limited by that fact that our criteria for diagnosis in each category was too broad, therefore, it was of limited value in lesions that had overlapping cytological features, especially basaloid neoplasms (pleomorphic adenoma, adenoid cystic carcinoma, basal cell adenoma, basal cell adenocarcinoma, myoepithelium and myoepithelial carcinoma).
In conclusion, this is the first study addressing agreement and discrepancies between ROSE and a final cytological diagnosis exclusive in salivary gland lesions. The present results show good-toexcellent agreement and comparably good diagnostic accuracy between ROSE and final cytological diagnosis. Moreover, a high concordance rate between malignant ROSE, final cytological and histological diagnosis suggests that malignant results of ROSE may be useful to facilitate an early clinical decision.
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